Keyword: Patent

Strategy & Management

Unified Patent System for Europe

27.01.2022 -

Innovation protection with the EU Unitary Patent will be more uniform and less costly, but it also carries risks.

Markets & Companies

Injecting Growth and Innovation

13.09.2019 - Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...

News

Johnson & Johnson Loses Another Patent Suit

25.01.2018 - US healthcare giant Johnson & Johnson has just been handed its second defeat in patent litigation this month. On Jan. 23, a US appeals court hearing J&J’s challenge to a lower...

News

UK Supreme Court Upholds Lily Alimta Patent

14.07.2017 - The UK Supreme Court has ruled in favor of US drugmaker Eli Lilly in a patent dispute with generics producer Actavis, now owned by Israel’s Teva, over the cancer drug Alimta. The...

News

DSM Dyneema Wins Israeli Patent Case

07.03.2017 - In the final instance, DSM Dyneema has won a protracted patent challenge against publicly held FMS Enterprises Migun of Tel Aviv. The firm had attempted to block the Dutch...

News

Teva CEO Erez Vigodman Steps Down

08.02.2017 - Erez Vigodman and the board of Israel’s Teva Pharmaceutical Industries – the world’s largest generics drugmaker – have announced that the chief executive, who has led the company...

News

Merck Settles Keytruda Patent Disputes

24.01.2017 - US drugmaker Merck has settled its patent dispute with rival Bristol-Myers Squibb (BMS) and Japan’s Ono Pharmaceutical over cancer immunotherapy Keytruda. Under terms of the...

News

Solvay Wins More Rare Earths Disputes

25.11.2016 - Solvay has won another two patent cases against affiliates of Neo Performance Materials relating to its range of OPtalys cerium/zirconium mixed oxides products. The Belgian group...